A seasoned meditator, after dedicating 15 years to cultivating inner stillness and quieting the ego, potentially experienced a similar altered state via a potent psychedelic. Initial brain scan data suggests a significant overlap in brain activity patterns between this profound meditative state and the effects induced by a modest dose of a particular psychedelic compound.
This emerging research, situated within a rapidly expanding field exploring the therapeutic and cognitive potential of psychedelics, highlights the compound 5-MeO-DMT. Found naturally in the venom of the North American toad, 5-MeO-DMT is drawing particular attention for its capacity to rapidly alter mental processes, often with less pronounced visual disturbances compared to other known psychedelics.
Research Methodology: Comparing States of Mind
To investigate these parallels, researchers led by Christopher Timmermann at University College London compared the brain activity of a highly experienced Buddhist lama with the effects of 5-MeO-DMT. This individual, a master from the Karma Kagyu school of Tibetan Buddhism, had accumulated over 54,000 hours of dedicated meditation practice.
The study involved three laboratory sessions for the lama. During each visit, he meditated continuously for up to an hour before either receiving a placebo, a low dose of 5-MeO-DMT, or a high dose. The scientific team meticulously recorded his brain activity throughout these sessions, subsequently gathering subjective reports on his thoughts and sense of self.
Low-Dose Psychedelics and Meditation: Convergent Neural Signatures
A striking observation emerged when the lama received a low dose of 5-MeO-DMT (5 milligrams). Brain scans revealed notable similarities in specific neural activity patterns to those observed during his profound meditation practice. Both states demonstrated an increase in alpha power, brain waves often associated with relaxed alertness, internally focused attention, and reduced responsiveness to external stimuli, when compared against his baseline and the placebo condition.
Furthermore, both the low-dose 5-MeO-DMT experience and advanced meditation led to a decrease in gamma activity. This type of brain wave is typically linked to active cognitive processing, focused attention, and memory functions.
According to Timmermann, these comparable states often produced a sense of equanimity, characterized by thoughts that appeared and dissolved without lingering. However, he noted that meditation, in this instance, fostered a more pronounced feeling of interconnectedness and mental clarity.
High-Dose Psychedelics: Dissolution of Self and Sensory Overload
In contrast, the higher dose of 5-MeO-DMT (12 milligrams) induced a different set of neural responses and subjective experiences. The lama reported a profound sense of disconnection from his environment and himself, including an overwhelming perception of white light. He described a complete absence of thought and a total loss of awareness regarding his body and the surrounding room.
This high-dose experience correlated with increased neuronal firing and elevated entropy, indicating more random and unpredictable firing patterns. Researchers interpret this as a sign that the higher dose profoundly overwhelmed the participant’s sensory input and cognitive processes. This contrasted sharply with the low-dose condition, which was associated with reduced neuronal firing and entropy.
Interpreting the Findings: Ego Dissolution and Awareness
The researchers posit that these findings offer a neural correlate for states of “ego dissolution” and “contentless awareness.” However, experts like Matthew Sacchet from Harvard Medical School caution that observed changes in brain activity do not automatically elucidate the full spectrum of subjective experiences.
It is important to acknowledge the limitations of this study. The research involved a single, highly experienced meditator, which may limit the generalizability of these findings. Furthermore, neuroimaging studies, particularly those involving psychedelics, can be susceptible to inconsistencies. The inherent difficulty in effectively ‘blinding’ participants in psychedelic research, due to the noticeable effects of these substances, also presents a challenge, though the lama in this study did not report such adverse cues.
Future Directions and Alternatives
Despite these considerations, Timmermann suggests that further investigation could reveal ways these findings might benefit a broader population, assuming safe and effective uses of 5-MeO-DMT are identified, mirroring the benefits observed in advanced meditation.
Current research by Timmermann is exploring whether 5-MeO-DMT could accelerate the progress of individuals in the early stages of their meditation practice. He strongly advises against attempting self-experimentation at home, particularly given that 5-MeO-DMT is illegal for general use in many regions.
Sacchet proposes that for those seeking the potential mental health advantages associated with psychedelics like 5-MeO-DMT, meditation may offer a practical and safer avenue. It appears to provide a pathway toward states that partially overlap with some psychedelic effects, without the inherent risks of toxicity or addiction.